Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03245021
Title Nivolumab Plus Rituximab in First-line Follicular Lymphoma gr 1-3A (1stFLOR)
Acronym 1stFLOR
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dr. Eliza Hawkes
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Ballarat Health Ballarat Victoria Australia Details
Eastern Health Box Hill Victoria 3128 Australia Details
Monash Health Clayton Victoria Australia Details
Austin Health Heidelberg Victoria 3084 Australia Details
St Vincent's Hospital Melbourne Victoria Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field